Carlisle Companies (NYSE: CSL) reported earnings on Oct. 23. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Carlisle Companies missed estimates on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue increased and GAAP earnings per share grew significantly.

Margins expanded across the board.

Revenue details
Carlisle Companies reported revenue of $910.2 million. The four analysts polled by S&P Capital IQ anticipated revenue of $930.0 million on the same basis. GAAP reported sales were 4.6% higher than the prior-year quarter's $870.5 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $1.08. The six earnings estimates compiled by S&P Capital IQ predicted $1.18 per share. GAAP EPS of $1.08 for Q3 were 27% higher than the prior-year quarter's $0.85 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 24.8%, 310 basis points better than the prior-year quarter. Operating margin was 12.8%, 340 basis points better than the prior-year quarter. Net margin was 7.6%, 140 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $833.0 million. On the bottom line, the average EPS estimate is $0.82.

Next year's average estimate for revenue is $3.64 billion. The average EPS estimate is $4.33.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 227 members out of 238 rating the stock outperform, and 11 members rating it underperform. Among 90 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 90 give Carlisle Companies a green thumbs-up, and give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Carlisle Companies is outperform, with an average price target of $61.60.